BCLAF1 and hepatocellular carcinoma: Moreover, Kaplan–Meier survival analysis using TCGA clinical data indicated that HCC patients with high mRNA expression levels of BCLAF1 had significantly shorter overall survival and disease-free survival compared to patients with low mRNA expression levels of BCLAF1 (Fig. 1p, q).